Pathophysiology of acute graft-versus-host disease from the perspective of hemodynamics determined by dielectric analysis

Table 1 The clinical information for each patient

Patient	Disease	Acute GVHD	Stage			Conditioning	Stem cell source	Decreased band3	Truncated PRDX2
No			Skin	Gut	Liver
1	AML	Ⅰ	1	0	0	MAC	URCB	No	No
2	HIM	0	0	0	0	RIC	URBMT	No	No
3	SCID	Ⅲ	2	3	1	RIC	URCB	Yes	Yes
4	SCID	Ⅲ	1	3	1	RIC	URCB	Yes	Yes
5	AML	Ⅰ	1	0	0	MAC	MSBMT	No	No
6	AML	Ⅱ	3	0	0	MAC	URBMT	No	No
7	DKC	Ⅲ	2	3	1	RIC	URBMT	Yes	Yes
8	ALL	0	0	0	0	MAC	URBMT	No	No
9	ALL	Ⅱ	3	0	0	MAC	URCB	No	No
10	ALL	Ⅱ	3	0	0	MAC	MSBMT	No	No
11	AML	Ⅰ	1	0	0	MAC	MSBMT	No	No
12	AML	Ⅲ	1	3	1	MAC	mis-RBMT	Yes	Yes
13	ALL	Ⅲ	1	2	1	MAC	URBMT	Yes	Yes
14	ALL	Ⅲ	1	2	1	MAC	URBMT	Yes	No
15	ALL	Ⅱ	3	0	0	MAC	mis-RBMT	No	No
16	SCN	Ⅰ	1	0	0	RIC	MSBMT	No	No

AML: Acute myeloid leukemia; HIM: Hyper IgM syndrome; SCID: Severe combined immunodeficiency; DKC: Dyskeratosis congenital; ALL: Acute lymphoblastic leukemia; SCN: Severe congenital neutropenia; MAC: Myeloablative conditioning; GVHD: Graft-versus-host disease; RIC: Reduced-intensity conditioning; URCB: Unrelated cord blood; URBMT: Unrelated bone marrow transplant; MSBMT: Matched sibling bone marrow transplant; mis-RBMT: Mismatched related bone marrow transplant.